Delivery Order SPE2DB24D9223-SPE2DB25FKEKN
- Not listed
- DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois, was awarded a firm fixed-price delivery order valued at $5,965.88 by the Defense Logistics Agency on August 7, 2025. The contract calls for the delivery of Rituxan 500 mg/50 ml vials, a biologic medication commonly used in oncology and rheumatology treatments. This delivery order was issued without a set-aside designation, and performance is scheduled for completion by August...
- The U.S. Defense Logistics Agency (DLA) awarded a firm fixed-price delivery order worth $38,347.10 to the woman-owned small business DMS Pharmaceutical Group Inc. based in Park Ridge, Illinois. The order is for the pharmaceutical product Rituxan 500 mg/50 ml vial and has a completion date of February 28, 2023. This order is part of a larger $499,999,999 Indefinite Delivery Contract (IDC) held by DMS Pharmaceutical Group with the DLA under the SPE2DB program. The IDC allows the DLA to issue...
- This is a federal contract award from the Defense Logistics Agency (DLA) to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois. The contract is a firm fixed-price delivery order worth $5,965.88 for the supply of Rituxan, a 500 mg/50 ml vial medication, with a period of performance through March 14, 2025. DMS Pharmaceutical Group Inc. holds a larger $499,999,999 Indefinite Delivery Contract (IDC) with the DLA under the SPE2DB...
- The U.S. Defense Logistics Agency awarded a firm fixed-price delivery order to DMS Pharmaceutical Group Inc., a for-profit, woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois. The $15,345.85 contract is for the supply of Rituxan 500 mg/50 ml vials. This delivery order is issued against DMS Pharmaceutical Group's larger $4,999,999 indefinite delivery contract with DLA under the SPE2DB program, which enables the agency to order a broad range of pharmaceutical...
- The Defense Logistics Agency (DLA) awarded a $32,045.00 firm fixed-price delivery order contract to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois. The contract is for the supply of 4558921358 units of the pharmaceutical product Rituxan (500 mg/50 mL vial, 50 mL) to support the medical supply needs of military healthcare facilities. This delivery order is issued under DMS Pharmaceutical Group's larger $499,999,999 Indefinite...
- This contract award to DMS Pharmaceutical Group Inc., a for-profit, woman-owned small business based in Park Ridge, Illinois, is for the delivery of pharmaceutical products to the U.S. government. The award, valued at $18,415.02, is a firm fixed-price delivery order issued by the Defense Logistics Agency (DLA) under the SPE2DB program, a multi-year indefinite delivery contract worth up to $4,999,999 that enables DLA to order a wide range of pharmaceuticals to support military health facilities...
- This federal contract award, valued at $16,466.00, was issued by the Defense Logistics Agency (DLA) to DMS Pharmaceutical Group Inc., a woman-owned small business based in Park Ridge, Illinois. The contract is a firm fixed-price delivery order for the pharmaceutical product Rituxan Hycela (1,400 mg-23,400 11.7 ml) and does not have a set-aside designation. DMS Pharmaceutical Group holds a larger five-year, $499,999,999 Indefinite Delivery Contract (IDC) with the DLA under the SPE2DB program,...
- This firm fixed-price delivery order was awarded by the Defense Logistics Agency (DLA) to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois. The $95,618.70 contract is for the delivery of Rituxan 500 mg/50 ml vials to support the medical supply needs of military healthcare facilities. DMS Pharmaceutical Group holds a $499,999,999 Indefinite Delivery Contract (IDC) with the DLA under the SPE2DB program, which enables the agency...
- This federal contract award was issued by the Defense Logistics Agency (DLA) to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois. The contract, a Firm Fixed Price Delivery Order valued at $41,649.97, is for the supply of Rituxan 500 mg/50 ml vials to support the recurring medical supply needs of military health facilities worldwide. DMS Pharmaceutical Group holds a significant indefinite delivery contract (IDC) with the DLA under...
- The Defense Logistics Agency issued a firm fixed-price delivery order valued at $5,965.88 to DMS Pharmaceutical Group Inc. for the supply of Rituxan 500 mg/50 mL vials on August 12, 2025. This delivery order represents a single transaction under DMS Pharmaceutical Group's larger Indefinite Delivery Contract with the DLA, which is valued at approximately $500 million and extends through November 2026. The award carries no set-aside designation, allowing the woman-owned small business based in...
- SPE2DB24D9223Indefinite Delivery Contract
- SPE2DB24D9223-SPE2DB25FKEKNDelivery Order
DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois, was awarded a delivery order valued at $5,965.88 by the Defense Logistics Agency (DLA) on August 21, 2025. The delivery order covers Rituxan 500 mg/50 ml vials for delivery to Park Ridge, Illinois, with a firm fixed-price contract type and an ultimate completion date of September 12, 2025. This award carries no set-aside designation, allowing the vendor to compete on an open basis despite its small business status. This delivery order is issued under DMS Pharmaceutical Group's larger Indefinite Delivery Contract with the DLA valued at $499,999,999 and valid through November 2026. The SPE2DB program contract enables the DLA to issue firm fixed-price delivery orders for a comprehensive range of pharmaceutical products supporting military health facilities worldwide, including branded and generic prescription drugs, biologics, and medical consumables. As a key supplier in the federal pharmaceutical supply chain, DMS Pharmaceutical Group has consistently secured contracts with the DLA covering medications spanning oncology treatments, vaccines, auto-injectors, and other specialized pharmaceutical products.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $6.0k | 8/21/25 |